Paradoxical Raynaud's phenomenon following iloprost infusion in a patient with systemic sclerosis

Scand J Rheumatol. 2023 Jan;52(1):91-92. doi: 10.1080/03009742.2022.2082054. Epub 2022 Jun 20.
No abstract available

MeSH terms

  • Humans
  • Iloprost / adverse effects
  • Raynaud Disease* / chemically induced
  • Raynaud Disease* / drug therapy
  • Scleroderma, Systemic* / complications
  • Scleroderma, Systemic* / drug therapy

Substances

  • Iloprost